The FDA has approved a once-daily formulation of bromfenac 0.09% ophthalmic solution for the treatment of postoperative inflammation and the reduction of ocular pain. Medscape Medical News
The FDA has approved a once-daily formulation of bromfenac 0.09% ophthalmic solution for the treatment of postoperative inflammation and the reduction of ocular pain. Medscape Medical News